ZA200804609B - Interferon-alpha and C-phycocyanin for the treatment of autoimmune diseases, allergic disease sand cancer - Google Patents

Interferon-alpha and C-phycocyanin for the treatment of autoimmune diseases, allergic disease sand cancer

Info

Publication number
ZA200804609B
ZA200804609B ZA200804609A ZA200804609A ZA200804609B ZA 200804609 B ZA200804609 B ZA 200804609B ZA 200804609 A ZA200804609 A ZA 200804609A ZA 200804609 A ZA200804609 A ZA 200804609A ZA 200804609 B ZA200804609 B ZA 200804609B
Authority
ZA
South Africa
Prior art keywords
phycocyanin
interferon
sand
cancer
alpha
Prior art date
Application number
ZA200804609A
Other languages
English (en)
Inventor
Penton Rol Giselle
Cervantes Llanos Majel
Penton Arias Eduardo
Garcia Del Barco Herrera Diana
Valenzuela Silva Carmen Maria
Lopez Saura Pedro Antonio
Guillen Nieto Gerardo Enrique
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of ZA200804609B publication Critical patent/ZA200804609B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200804609A 2005-10-28 2008-05-27 Interferon-alpha and C-phycocyanin for the treatment of autoimmune diseases, allergic disease sand cancer ZA200804609B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20050207A CU23581A1 (es) 2005-10-28 2005-10-28 Interferon alfa y c-ficocianina para el tratamiento de enfermedades autoinmunes, alérgicas y cáncer

Publications (1)

Publication Number Publication Date
ZA200804609B true ZA200804609B (en) 2009-02-25

Family

ID=37748615

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804609A ZA200804609B (en) 2005-10-28 2008-05-27 Interferon-alpha and C-phycocyanin for the treatment of autoimmune diseases, allergic disease sand cancer

Country Status (13)

Country Link
US (1) US8110182B2 (es)
EP (1) EP1955706A1 (es)
JP (1) JP2009513583A (es)
KR (1) KR20080066060A (es)
CN (1) CN101355958A (es)
AR (1) AR057565A1 (es)
AU (1) AU2006308342A1 (es)
BR (1) BRPI0617943A2 (es)
CA (1) CA2627531C (es)
CU (1) CU23581A1 (es)
RU (1) RU2008121248A (es)
WO (1) WO2007048357A1 (es)
ZA (1) ZA200804609B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101716332B (zh) * 2009-11-12 2012-03-07 中国药科大学 藻蓝蛋白用于防治糖尿病的用途
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
IT1403990B1 (it) * 2010-12-16 2013-11-08 Associazione Termalisti Isola D Ischia Cianobatterio della famiglia delle pseudanabaenaceae (oscillatoriales, cyanophyta), genere protolyngbya, specie protolyngbya sp. ceppo itd-01
CU23963B1 (es) * 2011-07-01 2013-12-11 Ct De Ingeniería Genética Y Biotecnología Composiciones farmacéuticas a partir de derivados de la c-ficocianina y combinaciones con interferones del tipo i para el tratamiento de enfermedades cerebrales isquémicas y neurodegenerativas
US20140314890A1 (en) * 2011-10-31 2014-10-23 The Florida International University Board Of Trustees Combination anti-cancer therapy
JP6306507B2 (ja) 2011-12-01 2018-04-18 国立大学法人 東京大学 制御性ｔ細胞の増殖または集積を誘導するヒト由来細菌
KR102115854B1 (ko) * 2017-11-13 2020-05-27 인하대학교 산학협력단 조류 색소 단백질을 포함하는 염증성 피부 질환 예방 또는 치료용 조성물
CN113198006B (zh) * 2021-05-12 2022-05-03 国珍健康科技（北京）有限公司 具有抑制lps诱导巨噬细胞分泌no功能的组成物及其应用和免疫药物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5865216A (ja) 1981-09-16 1983-04-18 Dainippon Ink & Chem Inc 抗腫瘍剤
US5163898A (en) * 1987-03-16 1992-11-17 The Regents Of The University Of California Medical treatment of tumors with phycocyanin

Also Published As

Publication number Publication date
CA2627531A1 (en) 2007-05-03
EP1955706A1 (en) 2008-08-13
JP2009513583A (ja) 2009-04-02
KR20080066060A (ko) 2008-07-15
BRPI0617943A2 (pt) 2016-10-25
CA2627531C (en) 2012-03-20
AR057565A1 (es) 2007-12-05
AU2006308342A1 (en) 2007-05-03
CN101355958A (zh) 2009-01-28
US8110182B2 (en) 2012-02-07
CU23581A1 (es) 2010-10-30
WO2007048357A1 (es) 2007-05-03
RU2008121248A (ru) 2009-12-10
US20090280087A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
EP1968607A4 (en) TREATMENT OF CANCER AND OTHER DISEASES
HRP20150175T1 (en) Means and methods for the treatment of tumorous diseases
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
ZA200804609B (en) Interferon-alpha and C-phycocyanin for the treatment of autoimmune diseases, allergic disease sand cancer
EP1928453A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RENAL DISEASES
IL214198A0 (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling
EP1814909A4 (en) USE OF AIMP2DX2 FOR THE DIAGNOSIS AND TREATMENT OF CANCER
IL182643A0 (en) Novel composition and methods for the treatment of immune related diseases
IL178815A0 (en) The treatment of respiratory disease
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
EP1931390A4 (en) COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES
ZA200800452B (en) Methods and compositions for the prevention and treatment of kidney disease
EP1863520A4 (en) USE OF INTERLEUKIN 17E FOR THE TREATMENT OF CANCER
ZA200708819B (en) Methods and compositions for the prevention and treatment of kidney disease
ZA200800981B (en) Use of SDF-1 for the treatment and/or prevention of neurological diseases
EP1680145A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
GB0410399D0 (en) The treatment of respiratory disease
ZA200607471B (en) Materials and methods for treatment of allergic disease
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
GB0320238D0 (en) Treatment of disease
GB0523961D0 (en) The treatment of ophthalmic diseases
WO2006020430A8 (en) Novel composition and methods for the treatment of immune related disease
EP1928247A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP1773882A4 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH SIGLEC-6
ZA200806095B (en) Means and methods for the treatment of tumorous diseases